Search Results

Filter
  • 1-10 of  355,566 results for ""Secondary Prevention""

Your Filters

Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

When Does Primary Prevention Encroach on Secondary Prevention?

  • Authors : Deshotels MR; Department of Medicine, Baylor College of Medicine, Houston, TX, USA.; Kotta PA

Subjects: Secondary Prevention*/Secondary Prevention*/Secondary Prevention*/methods ; Primary Prevention*/Primary Prevention*/Primary Prevention*/methods; Humans

  • Source: Current atherosclerosis reports [Curr Atheroscler Rep] 2024 Sep; Vol. 26 (9), pp. 511-519. Date of Electronic Publication: 2024 Jul 08.Publisher: Springer Country of Publication: United States NLM ID: 100897685 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Gender inequalities in secondary prevention of cardiovascular disease: a scoping review.

  • Authors : López Ferreruela I; Internal Medicine Service, Miguel Servet University Hospital, Saragossa, Spain. .; GRISSA Research Group. IIS Aragón, Aragon Health Sciences Institute, Saragossa, Spain. .

Subjects: Cardiovascular Diseases*/Cardiovascular Diseases*/Cardiovascular Diseases*/prevention & control ; Secondary Prevention*/Secondary Prevention*/Secondary Prevention*/methods; Humans

  • Source: International journal for equity in health [Int J Equity Health] 2024 Jul 23; Vol. 23 (1), pp. 146. Date of Electronic Publication: 2024 Jul 23.Publisher: BioMed Central Country of Publication: England NLM ID: 101147692 Publication Model: Electronic Cited Medium: Internet ISSN: 1475-9276

Record details

×
Academic Journal

Comparison of American and European Guideline Recommendations for Diagnostic Workup and Secondary Prevention of Ischemic Stroke and Transient Ischemic Attack.

  • Authors : Mulder MJHL; Departments of Neurology, Erasmus University Medical Center (M.J.H.L.M., T.Y.C., D.W.J.D.), Rotterdam, The Netherlands.; Cras TY

Subjects: Ischemic Attack, Transient*/Ischemic Attack, Transient*/Ischemic Attack, Transient*/prevention & control ; Ischemic Attack, Transient*/Ischemic Attack, Transient*/Ischemic Attack, Transient*/diagnosis ; Secondary Prevention*/Secondary Prevention*/Secondary Prevention*/methods

  • Source: Circulation [Circulation] 2024 Sep 03; Vol. 150 (10), pp. 806-815. Date of Electronic Publication: 2024 Sep 03.Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 0147763 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Discovery of orally bioavailable phenyltetrazolium derivatives for the acute treatment and the secondary prevention of ischemic stroke.

  • Authors : Lu Y; Department of Pharmacy, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, 310009, China; Hangzhou Institute of Innovative Medicine, Institute of Drug Discovery and Design, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, China.

Subjects: Ischemic Stroke*/Ischemic Stroke*/Ischemic Stroke*/prevention & control ; Ischemic Stroke*/Ischemic Stroke*/Ischemic Stroke*/drug therapy ; Neuroprotective Agents*/Neuroprotective Agents*/Neuroprotective Agents*/chemistry

  • Source: European journal of medicinal chemistry [Eur J Med Chem] 2024 Sep 05; Vol. 275, pp. 116542. Date of Electronic Publication: 2024 Jun 01.Publisher: Editions Scientifiques Elsevier Country of Publication: France NLM ID: 0420510 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
Academic Journal

Use of Cardiovascular Disease Secondary Prevention Medications in Four Middle East Countries in a Community Setting.

  • Authors : Yusufali A; Health Improvement Project Zanzibar, Zanzibar, United Republic of Tanzania.; Zidan M

Subjects: Secondary Prevention*/Secondary Prevention*/Secondary Prevention*/methods ; Cardiovascular Diseases*/Cardiovascular Diseases*/Cardiovascular Diseases*/prevention & control ; Cardiovascular Diseases*/Cardiovascular Diseases*/Cardiovascular Diseases*/epidemiology

  • Source: Global heart [Glob Heart] 2024 Aug 26; Vol. 19 (1), pp. 70. Date of Electronic Publication: 2024 Aug 26 (Print Publication: 2024).Publisher: Ubiquity Press Country of Publication: England NLM ID: 101584391 Publication Model: eCollection Cited Medium: Internet ISSN: 2211-8179

Record details

×
Academic Journal

Patient knowledge about risk factors, achievement of target values, and guideline-adherent secondary prevention therapies 12 months after acute myocardial infarction.

Subjects: Secondary Prevention*/Secondary Prevention*/Secondary Prevention*/methods ; Guideline Adherence* ; Myocardial Infarction*/Myocardial Infarction*/Myocardial Infarction*/prevention & control

  • Source: European heart journal. Acute cardiovascular care [Eur Heart J Acute Cardiovasc Care] 2024 Jul 24; Vol. 13 (7), pp. 537-545.Publisher: Oxford University Press Country of Publication: England NLM ID: 101591369 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Using status of secondary prevention medications in post-stroke dysphagia patients: time to raise awareness and develop special formulations.

  • Authors : Yu N; Centre for Drug Delivery Technology and Vaccine (Centric), Faculty of Pharmacy, Universiti Kebangsaan Malaysia, 50300, Kuala Lumpur, Malaysia.; Department of Pharmaceutical Preparation, General Hospital of Ningxia Medical University, No. 804, Shengli South Street, Yinchuan, 750004, China.

Subjects: Deglutition Disorders*/Deglutition Disorders*/Deglutition Disorders*/etiology ; Deglutition Disorders*/Deglutition Disorders*/Deglutition Disorders*/prevention & control ; Stroke*/Stroke*/Stroke*/complications

  • Source: Scientific reports [Sci Rep] 2024 Jul 04; Vol. 14 (1), pp. 15377. Date of Electronic Publication: 2024 Jul 04.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Drug intervention as an emerging concept for secondary prevention in patients with coronary disease.

  • Authors : Minami Y; Department of Cardiovascular Medicine, Kitasato University Hospital, 1-15-1 Kitasato, Minami-Ku, Sagamihara, 252-0375, Japan. .; Ako J

Subjects: Secondary Prevention*/Secondary Prevention*/Secondary Prevention*/methods ; Coronary Artery Disease* ; Hydroxymethylglutaryl-CoA Reductase Inhibitors*/Hydroxymethylglutaryl-CoA Reductase Inhibitors*/Hydroxymethylglutaryl-CoA Reductase Inhibitors*/therapeutic use

  • Source: Cardiovascular intervention and therapeutics [Cardiovasc Interv Ther] 2024 Jul; Vol. 39 (3), pp. 223-233. Date of Electronic Publication: 2024 Apr 08.Publisher: Springer Country of Publication: Japan NLM ID: 101522043 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1868-4297

Record details

×
Academic Journal

The impact of frailty on initiation, continuation and discontinuation of secondary prevention medications following myocardial infarction.

  • Authors : Doody H; Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Melbourne, Australia; Pharmacy Department, Launceston General Hospital, Tasmania, Australia

Subjects: Secondary Prevention*/Secondary Prevention*/Secondary Prevention*/methods ; Myocardial Infarction*/Myocardial Infarction*/Myocardial Infarction*/prevention & control ; Myocardial Infarction*/Myocardial Infarction*/Myocardial Infarction*/epidemiology

  • Source: Archives of gerontology and geriatrics [Arch Gerontol Geriatr] 2024 Jul; Vol. 122, pp. 105370. Date of Electronic Publication: 2024 Feb 13.Publisher: Elsevier Biomedical Press Country of Publication: Netherlands NLM ID: 8214379 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
Academic Journal

Effect of bempedoic acid on mortality and cardiovascular events in primary and secondary prevention: A post-hoc analysis of the CLEAR-outcomes trial.

  • Authors : Sayed A; Ain Shams University, Faculty of Medicine, Cairo, Egypt.; Brophy JM

Subjects: Cardiovascular Diseases*/Cardiovascular Diseases*/Cardiovascular Diseases*/prevention & control ; Cardiovascular Diseases*/Cardiovascular Diseases*/Cardiovascular Diseases*/mortality ; Dicarboxylic Acids*/Dicarboxylic Acids*/Dicarboxylic Acids*/therapeutic use

  • Source: International journal of cardiology [Int J Cardiol] 2024 Jul 01; Vol. 406, pp. 132074. Date of Electronic Publication: 2024 Apr 21.Publisher: Elsevier Country of Publication: Netherlands NLM ID: 8200291 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
  • 1-10 of  355,566 results for ""Secondary Prevention""